Wayland Signs 9,000 kgs Supply Agreement with Cannamedical for Export to Germany
Toronto and Munich-based Wayland Group, formerly MariCann (CSE:WAYL) (OTCQB:MRRCF) agreed to supply Cannamedical Pharma Gmbh, a licensed, privately owned importer and distributor of cannabis in Germany to over 2,200 pharmacies, with a minimum of 9,000 kilograms of EU-GMP certified cannabis flowers over a three-year term.
The companies have completed mandatory quality assurance and control audits and have scheduled the first shipment in December of 2018.
“The decision we made…to move to EU-GMP standards for all production, including cannabis flowers, followed by certification…this year by the German Health Authorities, provides Wayland with the opportunity to move a significant amount of product, in this case 9,000 kilograms to Germany, said Ben Ward, CEO of Wayland.
“We’re proud to be one of six companies worldwide…who exceed EU-GMP standards for dry cannabis flowers. This agreement will provide meaningful revenue and profit to the Company over the next three years as we build a sustainable business,” Ward continued.
“Being able to meet the exponentially growing demand of our European client base strengthens our position as the largest independent and privately-owned cannabis distributor in Germany. Cannamedical will formally introduce its CannaSativa®, CannaIndica® and Cannahybrid® product lines during next week’s German pain congress in Mannheim, Germany,” stated David Henn, CEO of Cannamedical.
Learn more about other exciting cannabis companies in the Cannin Report. Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll help you determine which cannabis companies to invest in.
Source Wayland press release
Wayland Signs 9,000 kgs Supply Agreement with Cannamedical for Export to Germany
About Cannin: Your Cannabis Stocks Resource
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Investing in Hemp Stocks
